pVITRO-HPV33 L1L2 Citations (1)

Originally described in: Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.
Kwak K, Jiang R, Wang JW, Jagu S, Kirnbauer R, Roden RB PLoS One. 2014 May 9;9(5):e97232. doi: 10.1371/journal.pone.0097232. eCollection 2014. PubMed Journal

---

Articles Citing pVITRO-HPV33 L1L2

Articles
Serum and cervicovaginal IgG immune responses against alpha7 and alpha9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination. Mboumba Bouassa RS, Pere H, Gubavu C, Prazuck T, Jenabian MA, Veyer D, Meye JF, Touze A, Belec L. PLoS One. 2020 May 18;15(5):e0233084. doi: 10.1371/journal.pone.0233084. eCollection 2020. PubMed

If you have published an article using this material, please email us at to have your article added to this page.